🛡️
ANTIRETROVIRAL WHO Essential Verified Rx Required
Tenofovir/Emtricitabine
Also known as:TruvadaDescovy "PrEP"
1 Protocols
2 views
Primary Use
HIV pre-exposure prophylaxis (PrEP) and treatment.
Also Used For:
HIV post-exposure prophylaxis
Chronic hepatitis B
Drug Classification
Medication Type
ANTIRETROVIRAL
Drug Class
NRTI combination
Dosage & Administration
Standard Dosage
300mg/200mg
Frequency
Once daily
Duration
Long-term for treatment, up to years for PrEP
Route
ORAL
Best Time
Same time every day
Important
Can take with or without food
Available Forms
Dosage Forms
TABLET
Available Strengths
300mg/200mg
Appearance
Blue caplet
Effectiveness
Success Rate
99% effective for PrEP when taken daily
High genetic barrier to resistance. Regular HIV testing required for PrEP users.
Treatment Protocols
HIV PrEP - Pre-Exposure Prophylaxis
For: HIV
Dosage
1 tablet (TDF 300mg / FTC 200mg)
Frequency
Once daily
Duration
Ongoing while at risk
99% effective when taken daily
Safety Information
Common Side Effects
NauseaHeadacheDiarrheaDizziness
Serious Side Effects (Seek Medical Help)
Kidney problems
Bone density loss
Lactic acidosis
Liver problems
Contraindications (Do Not Use If)
Severe kidney impairment
Unknown HIV status (for PrEP)
Acute HIV infection
Drug Interactions
Other nephrotoxic drugsAdefovirCidofovir
Pregnancy
Category B - Generally safe
Breastfeeding
Compatible with breastfeeding
Pricing Information
Mfg. Cost
$15
Global Avg. Price
$50
Patent Status
Brand and generic available
Prices may vary significantly by country, pharmacy, and insurance coverage. This is an average estimate.
Availability & Regulations
Prescription Required
Not OTC
Not Controlled
FDA Approval
2004
Available In
🇵🇭Philippines🇹🇭Thailand🇻🇳Vietnam🇸🇬Singapore🇲🇾Malaysia🇺🇸United States🇬🇧United Kingdom